Greenyn Biotechnology Co (ROCO:6846) Ending Cash Position : NT$523.6 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Greenyn Biotechnology Co Ending Cash Position?

Greenyn Biotechnology Co's Ending Cash Position for the quarter that ended in Mar. 2024 was NT$523.6 Mil.

Greenyn Biotechnology Co's quarterly Ending Cash Position declined from Sep. 2023 (NT$554.7 Mil) to Dec. 2023 (NT$533.5 Mil) and declined from Dec. 2023 (NT$533.5 Mil) to Mar. 2024 (NT$523.6 Mil).

Greenyn Biotechnology Co's annual Ending Cash Position increased from Dec. 2021 (NT$356.1 Mil) to Dec. 2022 (NT$370.3 Mil) and increased from Dec. 2022 (NT$370.3 Mil) to Dec. 2023 (NT$533.5 Mil).

Greenyn Biotechnology Co Ending Cash Position Historical Data

The historical data trend for Greenyn Biotechnology Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenyn Biotechnology Co Ending Cash Position Chart

Greenyn Biotechnology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

164.70

384.14

356.13

370.30

533.51

Greenyn Biotechnology Co Quarterly Data
	Dec19	Jun20	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial										396.00	543.81	554.68	533.51	523.56

Greenyn Biotechnology Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Greenyn Biotechnology Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	370.299	+	163.209
	=	533.5

Greenyn Biotechnology Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	533.508	+	-9.946
	=	523.6

Greenyn Biotechnology Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Greenyn Biotechnology Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Greenyn Biotechnology Co (ROCO:6846) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Greenyn Biotechnology Co Ltd (ROCO:6846) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

5th Floor, No 43 Keya Road, Daya District, Taichung, TWN

Website

https://www.greenynbio.com

Greenyn Biotechnology Co Ltd has developed Insumate patented sequenced peptide, Antromax Antrodia cinnamomea mycelia, and Zymologist fermented liquid.

Greenyn Biotechnology Co (ROCO:6846) Headlines

No Headlines